• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测试用于诊断根据国际宫颈内膜腺癌标准和分类(IECC)系统组织学分型的子宫颈恶性腺性肿瘤的算法。

Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.

机构信息

Departments of Pathology and Laboratory Medicine, University of Calgary and Alberta Precision Laboratories.

Alberta Health Services, Calgary, AB.

出版信息

Appl Immunohistochem Mol Morphol. 2022 Feb 1;30(2):91-98. doi: 10.1097/PAI.0000000000000988.

DOI:10.1097/PAI.0000000000000988
PMID:34799503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8857037/
Abstract

The International Endocervical adenocarcinoma Criteria and Classification (IECC) categorizes tumors into human papilloma virus (HPV) associated (HPVA), not associated (NHPV), and invasive adenocarcinoma not otherwise specified (IA NOS). HPVA and NHPV encompass 11 histotypes and an algorithm of mucin content, HPV ribonucleic acid (RNA), estrogen receptor and GATA3 is proposed for the diagnosis of most. In this study, the IECC algorithm's diagnoses were compared with hematoxylin and eosin (H&E) based IECC histotyping. Kappa statistics measured performance agreement. With additional markers, hierarchical clustering by random forest (RF) classification identified the most discriminating between tumor types, and investigated other algorithms. Three pathologists independently reviewed digitized H&E images of n=152 primary cervical adenocarcinomas for IECC histotype and mucin content, and tissue microarrays for expression of HPV RNA by in situ hybridization and 16 antibodies by immunohistochemistry. Results were finalized by consensus. There were n=113 HPVA, n=22 NHPV, and n=17 IA NOS. Mucin was obvious in n=36 and limited in n=116. Among n=124 with satisfactory test results, HPV RNA was positive in n=96, estrogen receptor in n=72, and GATA3 in n=15. The IECC algorithm diagnosed n=99 which agreed with H&E histotyping in n=64 for a fair κ of 0.36 (95% confidence interval, 0.21-0.50): n=12 were undiagnosed and n=13 were IA NOS. Small sample sizes restricted RF to HPVA versus NHPV which were discriminated by p16, HPV RNA, and MUC6 with an area under the curve of 0.74 (95% confidence interval, 0.58-0.90). The IECC algorithm for histotyping under-performed. The RF algorithmin for categorization was favorable, but validation in larger studies and investigation of additional algorithms to discriminate between all IECC histotypes are needed.

摘要

国际宫颈内膜腺癌分类(IECC)将肿瘤分为人乳头瘤病毒(HPV)相关(HPVA)、不相关(NHPV)和未另行指定的浸润性腺癌(IA NOS)。HPVA 和 NHPV 包括 11 种组织类型,并提出了一种基于粘蛋白含量、HPV 核糖核酸(RNA)、雌激素受体和 GATA3 的算法来诊断大多数肿瘤。在这项研究中,IECC 算法的诊断结果与基于苏木精和伊红(H&E)的 IECC 组织学类型进行了比较。Kappa 统计测量了性能一致性。通过随机森林(RF)分类的附加标记,层次聚类确定了肿瘤类型之间最具区分性的标记,并研究了其他算法。三名病理学家独立审查了 n=152 例原发性宫颈腺癌的数字化 H&E 图像,以进行 IECC 组织学类型和粘蛋白含量的评估,并通过原位杂交和免疫组织化学检查组织微阵列中 HPV RNA 和 16 种抗体的表达。结果通过共识最终确定。其中 n=113 例为 HPVA,n=22 例为 NHPV,n=17 例为 IA NOS。n=36 例有明显的粘蛋白,n=116 例有有限的粘蛋白。在 n=124 例具有满意检测结果的患者中,n=96 例 HPV RNA 阳性,n=72 例雌激素受体阳性,n=15 例 GATA3 阳性。IECC 算法诊断 n=99 例,与 H&E 组织学类型一致 n=64 例,kappa 值为 0.36(95%置信区间,0.21-0.50):n=12 例未诊断,n=13 例为 IA NOS。样本量小限制了 RF 仅用于区分 HPVA 与 NHPV,其鉴别特征为 p16、HPV RNA 和 MUC6,曲线下面积为 0.74(95%置信区间,0.58-0.90)。IECC 组织学分类算法表现不佳。RF 分类算法是有利的,但需要在更大的研究中验证,并研究其他算法来区分所有 IECC 组织学类型。

相似文献

1
Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.测试用于诊断根据国际宫颈内膜腺癌标准和分类(IECC)系统组织学分型的子宫颈恶性腺性肿瘤的算法。
Appl Immunohistochem Mol Morphol. 2022 Feb 1;30(2):91-98. doi: 10.1097/PAI.0000000000000988.
2
International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.国际宫颈内膜腺癌标准和分类(IECC):宫颈内膜浸润性腺癌的一种新的发病机制分类。
Am J Surg Pathol. 2018 Feb;42(2):214-226. doi: 10.1097/PAS.0000000000000986.
3
Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.基于 297 例浸润性宫颈腺癌的综合免疫组化评估的诊断算法建议。
Am J Surg Pathol. 2018 Aug;42(8):989-1000. doi: 10.1097/PAS.0000000000001090.
4
International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.国际宫颈内膜腺癌标准和分类:验证和观察者间可重复性。
Am J Surg Pathol. 2019 Jan;43(1):75-83. doi: 10.1097/PAS.0000000000001095.
5
Recent advances in invasive adenocarcinoma of the cervix.宫颈癌浸润性腺癌的最新进展。
Virchows Arch. 2019 Nov;475(5):537-549. doi: 10.1007/s00428-019-02601-0. Epub 2019 Jun 17.
6
Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization.使用国际宫颈管腺癌标准和分类系统评估人乳头瘤病毒(HPV)预测,并与p16免疫组织化学和HPV RNA原位杂交进行比较。
J Pathol Transl Med. 2020 Nov;54(6):480-488. doi: 10.4132/jptm.2020.07.18. Epub 2020 Aug 31.
7
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.国际宫颈内膜腺癌标准和分类(IECC):与不良临床病理特征和患者预后的相关性。
J Clin Pathol. 2019 May;72(5):347-353. doi: 10.1136/jclinpath-2018-205632. Epub 2019 Jan 24.
8
[Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].[根据国际宫颈腺癌标准与分类对宫颈内膜腺癌进行分类:286例临床病理及预后分析]
Zhonghua Bing Li Xue Za Zhi. 2021 Sep 8;50(9):1014-1019. doi: 10.3760/cma.j.cn112151-20210524-00374.
9
International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.国际宫颈内膜腺癌标准和分类(IECC):具有临床和分子特征的独立队列。
Int J Gynecol Pathol. 2021 Nov 1;40(6):533-540. doi: 10.1097/PGP.0000000000000764.
10
[Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].[不同检测标志物在宫颈管腺癌中的诊断价值及预后评估]
Zhonghua Zhong Liu Za Zhi. 2023 May 23;45(5):402-409. doi: 10.3760/cma.j.cn112152-20220705-00473.